Oscar Health (MEX:OSCR) 5-Year RORE % : -34.84% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:OSCR Oscar Health Inc MEX:OSCR
53 GF Score
Price MXN536.00
GF Value MXN373.65
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Oscar Health 5-Year RORE %?

Oscar Health MEX:OSCR +3.47% 53 5-Year RORE % is -34.84 as of Mar. 2026. GuruFocus rates MEX:OSCR with a GF Score™ of 53/100 and a GF Value™ of MXN373.65 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 17 Healthcare Plans companies, Oscar Health ranks worse than 76.47% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Oscar Health's 5-Year RORE % for the quarter that ended in Mar. 2026 was -34.84%.

The industry rank for Oscar Health's 5-Year RORE % or its related term are showing as below:

MEX:OSCR's 5-Year RORE % is ranked worse than
76.47% of 17 companies
in the Healthcare Plans industry
Industry Median: -2.41 vs MEX:OSCR: -34.84

Oscar Health  (MEX:OSCR) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Oscar Health 5-Year RORE % Related Terms


Oscar Health 5-Year RORE % Historical Data

* Premium members only.

The historical data trend for Oscar Health's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oscar Health 5-Year RORE % Chart

Oscar Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
5-Year RORE %
Get a 7-Day Free Trial 0.00 0.00 0.00 -54.33 -20.96

Oscar Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -56.52 -40.20 -26.57 -20.96 -34.84

MEX:OSCR vs MOH, ALHC, CLOV: 5-Year RORE % Comparison

For the Healthcare Plans subindustry, Oscar Health's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oscar Health 5-Year RORE % vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Oscar Health's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where Oscar Health's 5-Year RORE % falls into.


MEX:OSCR
53GF Score
Oscar Health Inc MEX:OSCR
5-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oscar Health 5-Year RORE % Calculation

Oscar Health's 5-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( -11.479--54.596 )/( -120.699-0 )
=43.117/-120.699
=-35.72 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 5-year before.

Frequently Asked Questions Learn more about 5-Year RORE % →
What does a 5-Year RORE % of -34.84 mean?
Oscar Health (MEX:OSCR) has a 5-Year RORE % of -34.84 as of Mar. 2026. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on Oscar Health and its competitors. According to the industry distribution chart, Oscar Health ranks #13 out of 17 companies in the Healthcare Plans industry, placing it in the top 76.5%.
Is Oscar Health's 5-Year RORE % too high?
Oscar Health's current 5-Year RORE % is -34.84. Based on the distribution chart, Oscar Health ranks #13 out of 17 companies in the Healthcare Plans industry, which is in the bottom quartile relative to peers. Overall, Oscar Health has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Oscar Health's 5-Year RORE % compare to MOH and ALHC?
According to the Healthcare Plans industry distribution chart, Oscar Health ranks #13 out of 17 companies for 5-Year RORE %. This places Oscar Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year RORE % for a Healthcare Plans company?
A good 5-Year RORE % depends on the Healthcare Plans industry context. However, 5-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year RORE % mean?
A high 5-Year RORE % can signal that a stock is expensive relative to its fundamentals. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on Oscar Health and its competitors. Oscar Health's current 5-Year RORE % is -34.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oscar Health stock overvalued right now?
Based on GuruFocus' analysis, Oscar Health (MEX:OSCR) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN373.65, compared to a current price of MXN536.00 — trading 43.4% above its estimated fair value. The current 5-Year RORE % is -34.84. Oscar Health's overall GF Score™ is 53/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year RORE % calculated?
5-Year RORE % is calculated from a company's financial statements. For Oscar Health (MEX:OSCR), the current 5-Year RORE % is -34.84 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oscar Health (MEX:OSCR) Overvalued in 2026?

Based on GuruFocus' analysis, Oscar Health stock appears to be overvalued. The current stock price of MXN536.00 is trading 43.4% above its estimated GF Value™ of MXN373.65. GuruFocus considers Oscar Health to be Significantly Overvalued.

Key valuation signals for MEX:OSCR:

  • 5-Year RORE %: -34.84
  • GF Value™: MXN373.65 vs. price of MXN536.00 (43.4% above fair value)
  • GF Score™: 53/100 with 5 warning signs

No single metric tells the full story. See the MEX:OSCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Oscar Health Business Description

Address 75 Varick Street, 5th Floor, New York, NY, USA, 10013
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
53GF Score

Get the complete analysis for MEX:OSCR

5-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN536.00
Price
MXN373.65
GF Value